Skip to main content

Advertisement

SpringerLink
Log in

Treatment of Pancreatic Adenocarcinoma in Elderly Patients over 75 Years of Age: A Retrospective Series of 129 Patients

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Purpose

To better know the presentation and outcome of pancreatic adenocarcinoma in patients above 75 years of age.

Method

Retrospective analysis of consecutive patients with a pancreatic adenocarcinoma seen in the Comprehensive Cancer Center of Marseille between January 2002 and January 2012 was used.

Results

During these 10 years, 129 patients older than 75 years of age were seen, 61 females and 68 males, median age 78. At diagnosis, the tumor was metastatic in 45 %. First line treatments were: surgical resection in 22 cases, radio-chemotherapy in 20 cases (1 operated on later), systemic chemotherapy in 59 cases, and best supportive care alone in 28 cases. Resection was possible in 19 cases and was R0 in 17; post-operative mortality was 0 %, and half received adjuvant chemotherapy. Median overall survival was 43 months with a 2-year overall survival of 64 %. For locally advanced tumor, 16 received best supportive care and 33 a specific treatment (20 cases of radio-chemotherapy). Median overall survival was 9.1 months and 2-year overall, survival was 6.1 %. Among the 58 metastatic patients, 79 % received systemic chemotherapy (most by gemcitabine); tolerance was correct in half. Median overall survival was 4.7 months, with a 2-year overall survival of 5.3 %.

Conclusions

Surgery of pancreatic adenocarcinoma is feasible and safe in elderly patients with good outcomes. In advanced and metastatic patients, the outcome is poor despite a correct tolerance of systemic chemotherapy. Randomized trials specially designed for this population are urgently needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics 2010. CA Cancer J Clin. 2010;60:277–300.

    Article  PubMed  Google Scholar 

  2. Hill C, Doyon F. The frequency of cancer in France in year 2002, and trends since 1968. Bull Cancer. 2006;93:7–11.

    PubMed  Google Scholar 

  3. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the monitoring of cancer incidence in Japan project. Jpn J Clin Oncol. 2009;39:850–8.

    Article  PubMed  Google Scholar 

  4. De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999–2007 by country and age : results of EUROCARE-5 – a population based study. Lancet Oncol. 2014;15:23–34.

    Article  PubMed  Google Scholar 

  5. Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362:1605–17.

    Article  CAS  PubMed  Google Scholar 

  6. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364:1817–25.

    Article  CAS  PubMed  Google Scholar 

  7. Von Hoff D, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-Paclitaxel plus gemcitabine. N Engl J Med. 2013;369:1691–703.

    Article  Google Scholar 

  8. Von Hoff DD, Ramanathan RK, Borad MJ, et al. Gemcitabine plus nab-Paclitaxel is an active regimen in patients with advanced pancreatic cancer : a phase I/II trial. J Clin Oncol. 2011;29:4548–54.

    Article  Google Scholar 

  9. Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer : an overview. Nat Rev Gastroenterol Hepatol. 2009;6:699–708.

    Article  PubMed  Google Scholar 

  10. Baine M, Sahak F, Lin C, Chakraborty S, Lyden E, Batra SK. Marital status and survival in pancreaticn cancer patients : a SEER, based analysis. PLoS One. 2011;6, e21052.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Raoul JL, Turrini O, Goncalves A, Gilabert M, Giovannini M, Rousseau F. Why is pancreatic cancer difficult to treat in the elderly? Aging Health. 2012;8:301–8.

    Article  CAS  Google Scholar 

  12. Hartwig W, Werner J, Jäger D, Debus J, Büchler MW. Improvement of surgical results for pancreatic cancer. Lancet Oncol. 2013;14:e476–85.

    Article  PubMed  Google Scholar 

  13. Fong Y, Blumgart L, Fortner JG, Brennan MF. Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg. 1995;222:426–37.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Lahat G, Sever R, Lubezky N, et al. Pancreatic cancer : surgery is a feasible therapeutic option for elderly patients. World J Surg Oncol. 2011;9:1–8.

    Article  Google Scholar 

  15. Hatzaras I, Schmidt C, Klemanski D, et al. Pancreatic resection in the octogenarian: a safe option for pancreatic malignancy. J Am Coll Surg. 2011;212:373–7.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Turrini O, Paye F, Bachellier P, Sauvanet A, Sa Cunha A, Le Treut YP, et al. Pancreatectomy for adenocarcinoma ijn elderly patients: postoperative outcomes and long term results. A study of the French Surgical Association. Eur J Surg Oncol. 2013;39:171–8.

    Article  CAS  PubMed  Google Scholar 

  17. Oettle H, Neuhaus P, Hochhaus A, et al. Adjuvant chemotherapy with gemcitabine and long term outcomes among patients with resected pancreatic cancer. The CONKO-001 randomized trial. JAMA. 2013;310:1473–81.

    Article  CAS  PubMed  Google Scholar 

  18. Neoptolemos JP, Stocken DD, Bassi C, et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA. 2010;304:1073–81.

    Article  CAS  PubMed  Google Scholar 

  19. Ducreux M, Rougier P, Pignon JP, Douillard JY, Seitz JF, Bugat R, et al. A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma. Ann Oncol. 2002;13:1185–91.

    Article  CAS  PubMed  Google Scholar 

  20. Dahan L, Bonnetain F, Ychou M, Mitry E, Gasmi M, Raoul JL, et al. Combination 5-fluorouraci, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301). Gut. 2010;59:1527–34.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Hentic O, Dreyer C, Rebours V, Zappa M, Levy P, Raymond E, et al. Gemcitabine in elderly patients with advanced pancreatic cancer. World J Gastroenterol. 2011;17:3497–502.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Yukisawa S, Ishii H, Matsuyama M, Kuraoka K, Takano K, Kamei A, et al. Outcomes and tolerability of systemic chemotherapy for pancreatic or biliary cancer patients aged 75 years or older. Jpn J Clin Oncol. 2011;41:76–80.

    Article  PubMed  Google Scholar 

  23. Loehrer Sr PJ, Feng Y, Cardenes H, Wagner L, Brell JM, Cella D, et al. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol. 2011;29:4105–12.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Chauffert B, Mornex F, Bonnetain F, Rougier P, Mariette C, Bouche O, et al. Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study. Ann Oncol. 2008;19:1592–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

SIRIC (grant INCa-DGOS-INSERM 6038)

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Paoli-Calmettes Institute, BP 156, 13273, Marseille, France

    Sandrine Oziel-Taieb, Marjorie Faure, Marine Gilabert, Frederique Rousseau & Jean-Luc Raoul

  2. Statistical Unit, Paoli-Calmettes Institute, BP 156, 13273, Marseille, France

    Aurélie Autret

  3. Department of Surgical Oncology, Paoli-Calmettes Institute, BP 156, 13273, Marseille, France

    Olivier Turrini

  4. Department of Radiotherapy, Paoli-Calmettes Institute, BP 156, 13273, Marseille, France

    Laurence Moureau-Zabotto

  5. Department of Interventional Endoscopy, Paoli-Calmettes Institute, BP 156, 13273, Marseille, France

    Marc Giovannini

Authors
  1. Sandrine Oziel-Taieb
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marjorie Faure
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marine Gilabert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Aurélie Autret
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Olivier Turrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Laurence Moureau-Zabotto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Marc Giovannini
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Frederique Rousseau
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jean-Luc Raoul
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean-Luc Raoul.

Ethics declarations

Conflict of Interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oziel-Taieb, S., Faure, M., Gilabert, M. et al. Treatment of Pancreatic Adenocarcinoma in Elderly Patients over 75 Years of Age: A Retrospective Series of 129 Patients. J Gastrointest Canc 47, 15–19 (2016). https://doi.org/10.1007/s12029-015-9774-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-015-9774-4

Keywords

Search

Navigation